Home Tags Epivax

Tag: Epivax

Five Questions With: Carol Malysz

In her role as RI Bio’s executive director, Carol Malysz oversees the group’s coordination with health care organizations, life sciences companies, academic centers and...
CONFIDENCE WANING? Matt Fair, center, of Hayes & ­Sherry Real Estate Services, listens with colleagues during PBN’s first Economic Trends Summit in Providence on Feb. 15. Panelists said perennial concerns such as rising health care costs and uncertainty about changing federal policies are dampening optimism about an otherwise strong economy.
 / PBN PHOTO/RUPERT WHITELEY

Optimism tempered by uncertainty

Rhode Island’s economy is doing well, but a handful of perennial bugaboos, along with actions at the federal level, have dampened the business community’s...
SECOND WAVE: Initially renovated in 2003, Rising Sun Mills, at 166 Valley St. in Providence, is going through a second wave of renovation for new tenants. Standing in front of the entry area are, from left, H. LeBaron “Barry” Preston, principal, Armory Revival Co.; Robert “BJ” E. Dupré Jr., principal, Armory Revival; Seth Zeren, director of development, Armory Management Co.; and Mark Van Noppen, vice president and managing director, Armory Revival.
 / PBN PHOTO/MICHAEL SALERNO

Rising Sun Mills undergoes remodel to welcome new tenants

Four years ago, the departure of Dassault Systèmes from the Rising Sun Mills for a suburban site did more than leave a vast opening...
EPIVAX AND CUBRC have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to establish best practices and procedures for assessing generic peptides and related impurities for immunogenic potential. EpiVax CEO and Chief Science Officer Dr. Anne S. De Groot said generic peptides drugs are a quickly growing market. / PBN FILE PHOTO/MICHAEL SALERNO

EpiVax and CUBRC win $1M FDA contract to establish best practices...

PROVIDENCE – EpiVax Inc. and CUBRC Inc. have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to...
PROVIDENCE MAYOR Jorge O. Elorza said the Providence Business Loan Fund was revamped under his administration and the program so far has provided more than $2.4 million in loans to local small businesses duriing his administration. / PBN FILE PHOTO/MICHAEL SALERNO

Elorza emphasizes Providence business loan program

PROVIDENCE – Mayor Jorge O. Elorza recently toured local businesses helped by the Providence Business Loan Fund. Elorza, running against two democratic challengers in the...

De Groot, EpiVax founder and URI professor, honored by her alma...

SOUTH KINGSTOWN – Dr. Anne S. De Groot, founder of EpiVax Inc. and a professor at the College of the Environmental and Life Sciences...
EPIVAX WILL celebrate its 20th anniversary in a new Olneyville office at 166 Valley St. June 15.

EpiVax moves growing staff to Olneyville

PROVIDENCE — Immunology engineering biotech firm EpiVax Inc. continues an eventful anniversary year with a new headquarters at 188 Valley St. in the Rising...
EPIVAX HAS WON a $324,000 grant to develop a web tool that will quickly determine whether Pompe disease patients are at risk for an immune response to enzyme replacement therapy.

EpiVax wins $324K NIH grant to improve Pompe disease treatment

PROVIDENCE — EpiVax Inc. has received a $324,980 Small Business Innovation Research grant to continue development of a web-based test for people at risk...
SELLING R.I.: Jesse Saglio, right, the new president and chief operating officer of R.I. Commerce Corp. at a recent public meeting of the agency’s board. He says Commerce will step up its focus on helping local and small businesses this year. / PBN PHOTO/MICHAEL SALERNO

New Commerce RI President Jesse Saglio promises ‘more of the same’...

Since October 2015, Jesse Saglio, 46, has been a key behind-the-scenes player at R.I. Commerce Corp., most recently serving as managing director and head...
EPIVAX PRESIDENT AND CEO Dr. Anne S. De Groot. EpiVax has launched a venture-backed spinoff, Epivax Oncology. / PBN FILE PHOTO

EpiVax launches EpiVax Oncology for personalized cancer vaccines

PROVIDENCE — Immunolgy engineering biotech firm EpiVax Inc. has launched EpiVax Oncology Inc., a venture-backed spinoff focused on the development of personalized therapeutic cancer...
- Featured Event -

Latest News